Guardant Health EBITDA vs. Net Income
| GH Stock | USD 32.65 1.67 5.39% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -433.3 M | Current Value -411.6 M | Quarterly Volatility 191.2 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.43 | 0.5974 |
|
|
For Guardant Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Guardant Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Guardant Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Guardant Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Guardant Health over time as well as its relative position and ranking within its peers.
Guardant |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Guardant Health Net Income vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Guardant Health's current stock value. Our valuation model uses many indicators to compare Guardant Health value to that of its competitors to determine the firm's financial worth. Guardant Health is rated below average in ebitda category among its peers. It also is rated below average in net income category among its peers . As of now, Guardant Health's EBITDA is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guardant Health's earnings, one of the primary drivers of an investment's value.Guardant Health's Earnings Breakdown by Geography
Guardant Net Income vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Guardant Health |
| = | (433.31 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Guardant Health |
| = | (479.45 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Guardant Net Income Comparison
Guardant Health is currently under evaluation in net income category among its peers.
Guardant Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Guardant Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Guardant Health will eventually generate negative long term returns. The profitability progress is the general direction of Guardant Health's change in net profit over the period of time. It can combine multiple indicators of Guardant Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -3.7 M | -3.9 M | |
| Net Interest Income | 32.8 M | 34.4 M | |
| Interest Income | 35.4 M | 37.1 M | |
| Operating Income | -564.7 M | -536.5 M | |
| Net Loss | -479.4 M | -455.5 M | |
| Income Before Tax | -478.8 M | -454.8 M | |
| Total Other Income Expense Net | 86 M | 90.3 M | |
| Net Loss | -589.1 M | -559.7 M | |
| Net Loss | -479.4 M | -455.5 M | |
| Income Tax Expense | 685 K | 719.2 K | |
| Non Operating Income Net Other | -95.8 M | -91.1 M | |
| Change To Netincome | 119.9 M | 70.3 M | |
| Net Loss | (4.28) | (4.50) | |
| Income Quality | 0.68 | 0.74 | |
| Net Income Per E B T | 1.00 | 0.80 |
Guardant Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Guardant Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Guardant Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Guardant Health's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Guardant Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Use Investing Themes to Complement your Guardant Health position
In addition to having Guardant Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Warren Buffett Holdings Thematic Idea Now
Warren Buffett Holdings
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
To fully project Guardant Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Guardant Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Guardant Health's income statement, its balance sheet, and the statement of cash flows.